Legend Biotech (LEGN) Assets Average (2020 - 2025)

Legend Biotech (LEGN) has 6 years of Assets Average data on file, last reported at $1.7 billion in Q4 2025.

• In Q4 2025, Assets Average rose 1.19% year-over-year to $1.7 billion; the TTM figure through Dec 2025 stood at $1.7 billion (up 1.19% YoY), while the FY2025 annual figure was $1.7 billion, down 3.27% from the prior year.
• Assets Average rose to $1.7 billion in Q4 2025, from $1.7 billion in the prior quarter.
• Across five years, Assets Average topped out at $308.1 billion in Q2 2021 and bottomed at $844.4 million in Q3 2021.
• A 5-year average of $37.6 billion and a median of $1.7 billion in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2021 — Assets Average tumbled 99.89% — and 2024, when it jumped 42.65%.
• Year by year, Assets Average stood at $966.6 million in 2021, then rose by 11.92% to $1.1 billion in 2022, then soared by 70.45% to $1.8 billion in 2023, then decreased by 7.64% to $1.7 billion in 2024, then grew by 1.19% to $1.7 billion in 2025.
• The last three Assets Average figures came in at $1.7 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.7 billion (Q2 2025), per Business Quant data.

Peer Comparison